Achillion Pharmaceuticals, Inc. (ACHN) stock prices updated...

Achillion Pharmaceuticals, Inc. stock price

Achillion Pharmaceuticals, Inc. latest news:

  • 11/16/2017 13:36:00

    Here's Why Achillion Pharmaceuticals Is Soaring 19.5% Today

    The company's story is finally untied from its failed relationship with Johnson & Johnson.

  • 11/15/2017 20:29:40

    BRIEF-Achillion announces pricing of secondary offering of common stock

    Achillion Pharmaceuticals Inc(ACHN). * Achillion announces pricing of secondary offering of common stock. * Says secondary public offering of 18.4 million common shares priced at $2.75per share Source text for Eikon: Further company coverage:

  • 11/14/2017 14:34:02

    Achillion shares drop as J&J to sell large stake

    Achillion Pharmaceuticals Inc. shares fell in the extended session Tuesday after the drug developer reported promising early data on one of its kidney-disease treatments but said a large stakeholder was selling shares in a secondary offering. Achillion shares fell 9.2% to $3.35 after hours. Achillion said Johnson & Johnson Inc.'s venture capital arm, Johnson & Johnson Innovation-JJDC Inc., will sell 18.4 million shares of Achillion in a public offering and that Achillion would not receive proceeds. Achillion has 136.9 million shares outstanding. Separately, the company said early data from its mid-stage clinical trial for ACH-4471 showed the drug reduced protein in the urine by more than 50% in patients with C3 glomerulopathy, a rare disease where protein deposits build up in the kidneys.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit for more information on this news.

  • More trends:

    ACI Worldwide, Inc.ACIW | ACNB CorporationACNB | Acorda Therapeutics, Inc.ACOR | Actions Semiconductor Co., Ltd.ACTS | Active Power, Inc.ACPW | Activision Blizzard, IncATVI | Actua CorporationACTA | Acura Pharmaceuticals, Inc.ACUR | Acxiom CorporationACXM | Adamas Pharmaceuticals, Inc.ADMS |